News from the healthcare data industry
SAN FRANCISCO, Feb. 14, 2022 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board. The new board members will help the company develop technology, data, partnership and growth strategies designed to increase its share of the global decentralized clinical trial…
The following hospital and health system executive moves have been reported by or shared with Becker’s Hospital Review since Feb. 4: 1. Scott Puccino became CFO of New York City-based Weill Cornell Medicine. 2. Chase Redden was named CFO of HCA Houston Healthcare Clear Lake in Webster, Texas, and HCA Houston Healthcare Mainland in Texas City,…
Posted 11 February 2022 | By Joanne S. Eglovitch The US Food and Drug Administration (FDA) should adopt updated data standards that accommodate the “evolving and emerging” nature of real-world data not currently reflected in the Data Standards Catalogue, according to industry comments on the agency’s draft guidance. Overall, comments from…
Radicle Science launches several blinded placebo-controlled clinical trials on rare cannabinoids with 10,000 participants in the first half of 2022 on the heels of completing 25 large-scale CBD studies in 2021. February 10, 2022 06:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Radicle Science, a transformative healthtech B-corp validating health and…
February 10, 2022 05:45 AM Eastern Standard Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (“Palantir,” NYSE:PLTR), a leading builder of operating systems for the modern enterprise, today announced a new one year extended partnership with Ferrari to bring its world class data and analytics technology to Scuderia Ferrari. In addition to Scuderia…
Feb 9 (Reuters) – The European Medicines Agency has set up a new centre to collect and mine more public health data from EU member states to improve the review of new drugs and provide them more quickly to patients. So-called Real World Evidence (RWE) from hospitals and physicians’ practices…
February 09, 2022 06:55 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO® and other therapies in Loxo Oncology at Lilly’s pipeline. The partnership will initially explore…
Tempus Announces the Acquisition of Highline Sciences February 08, 2022 08:00 AM Eastern Standard Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced the acquisition of Highline Sciences, a specialized, full-service clinical contract research organization (CRO) focused on oncology. “Joining forces with Tempus creates a unique…
SAN FRANCISCO, Feb. 8, 2022 /PRNewswire/ — Vault Health, a national leader in remote diagnostics and COVID testing, and Datavant, the leader in helping organizations securely de-identify and connect health data, today announced a collaboration to enable life sciences and healthcare organizations to connect their data to Vault’s vast set of COVID-19 test…
New Nature Biotechnology publication advances efforts to improve genome sequencing information for diagnosis and treatment of diseaseFebruary 08, 2022 08:03 AM Eastern Standard Time MOUNTAIN VIEW, Calif. & HOUSTON–(BUSINESS WIRE)–Researchers from National Institute of Standards and Technology (NIST), Baylor College of Medicine and DNAnexus, Inc., together with other members of the Genome in a Bottle (GIAB) consortium,…